Search results
Results From The WOW.Com Content Network
Flurazepam [2] (marketed under the brand names Dalmane and Dalmadorm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties.
All benzodiazepines are categorized as Schedule IV substances under the Controlled Drugs and Substances Act. [ 217 ] In the United Kingdom, benzodiazepines are Class C controlled drugs, carrying the maximum penalty of 7 years imprisonment, an unlimited fine or both for possession and a maximum penalty of 14 years imprisonment, an unlimited fine ...
The specific classification of any given drug or other substance is usually a source of controversy, as is the purpose and effectiveness of the entire regulatory scheme. The term "controlled substance" means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter.
[5] [6] The Anatomical Therapeutic Chemical Classification System (ATC), the most widely used drug classification system, assigns drugs a unique ATC code, which is an alphanumeric code that assigns it to specific drug classes within the ATC system. Another major classification system is the Biopharmaceutics Classification System.
Oxycodone is a controlled substance under Schedule I of the Controlled Drugs and Substances Act (CDSA). [156] Canadian oxycodone HCL/acetaminophen 5/325 mg tablet. In February 2012, Ontario passed legislation to allow the expansion of an already existing drug-tracking system for publicly funded drugs to include those that are privately insured.
The US Drug Enforcement Administration has classified modafinil as a Schedule IV controlled substance; [2] [8] the medicine is recognized for having valid medical uses with low addiction potential. [ 120 ] [ 54 ] The International Narcotics Control Board does not classify it as a narcotic or a psychotropic substance.
The drug is not expected to differ from psilocybin or psilocin in terms of safety. [4] [1] 4-AcO-DMT is modestly less potent by weight than psilocybin in animals when they are given at equimolar doses. [2] 4-AcO-DMT was first described in a patent by Albert Hofmann in 1963 and its chemical synthesis was improved by David E. Nichols and ...